According to this report, the $1.2 billion 2008 global market for products
used to monitor and treat neonatal and perinatal patients will grow at a CAGR
of 5.2% reaching over $1.5 billion by 2013.
Growth in Asia-Pacific and other international markets will be driven by
expanding populations and increasing birth rates, greater demand for these
products, and the growing availability of low-cost or locally manufactured
technologies. Developing countries account for the vast majority of annual
births and preterm infants, which are at risk for developing conditions
requiring ventilation, warming therapy, jaundice management, and neonatal
monitoring. Driven by a growing middle class, demand is increasing for these
products, which are well-established in the developed markets of the U.S.,
Western Europe, and Japan. The growing availability of low-cost and locally
manufactured products will continue to drive sales of new units in these
countries.
Sales growth will be relatively flat in the U.S. and Europe through 2013.
Revenues will be driven by replacement technologies and accessories, and
hospitals will continue to prefer devices that offer multiple functions. In
infant ventilation, sales will increasingly shift towards comprehensive units
capable of treating a full range of patients including neonatal, pediatric,
and adult patients. Hybrid warming devices that can be configured as either
open warmers or closed incubators will also be preferred. Specialty products
such as high-frequency ventilators will also see strong sales growth through
2013. Homecare will represent a growing source for sales of monitoring and
jaundice management products.
This report includes coverage of infant ventilation, infant warming, jaundice
management, and monitoring products in the U.S., European, Asia-Pacific, and
Rest-of-World (ROW) markets. Featured companies include Atom Medical, Draeger
Medical, Fisher & Paykel Healthcare, GE Healthcare, Maquet (Getinge),
Respironics (Philips Healthcare), Spacelabs Healthcare (OSI Systems), and
Viasys (Cardinal Health), amongst others.
Table of Contents
Table of Contents
EXECUTIVE SUMMARY
Regional Markets
The United States
Europe
Asia-Pacific and the Rest of the World
Product Markets
Infant Ventilation
Infant Warming
Jaundice Management
Neonatal and Perinatal Monitoring
EXHIBIT ES-1: NEONATAL AND PERINATAL MONITORING AND TREATMENT PRODUCTS,
GLOBAL MARKET FORECAST, 2006-2013
EXHIBIT ES-2: GLOBAL MARKET FORECAST BY PRODUCT SEGMENT, 2006-2013
EXHIBIT ES-3: GLOBAL MARKET FORECAST FOR INFANT VENTILATION PRODUCTS,
2006-2013
EXHIBIT ES-4: GLOBAL MARKET FORECAST FOR INFANT WARMING PRODUCTS, 2006-2013
EXHIBIT ES-5: GLOBAL MARKET FORECAST FOR JAUNDICE MANAGEMENT PRODUCTS,
2006-2013
EXHIBIT ES-6: GLOBAL MARKET FORECAST FOR NEONATAL AND PERINATAL MONITORING
SYSTEMS, 2006-2013
1. OVERVIEW
1.1 Technology Trends
1.2 Geographic Trends
EXHIBIT 1-1: NEONATAL AND PERINATAL MONITORING AND TREATMENT PRODUCT
OVERVIEW
EXHIBIT 1-2: MAJOR TECHNOLOGY TRENDS
EXHIBIT 1-3: ANNUAL BIRTHS BY GEOGRAPHIC REGION, 2006-2013
EXHIBIT 1-4: REGIONAL FACTORS
2. INFANT VENTILATION
2.1 Clinical Indications
2.2 Nasal CPAP
2.3 Conventional Ventilators
2.4 High Frequency Ventilation
EXHIBIT 2-1: INFANT VENTILATORS BY TYPE, 2008
EXHIBIT 2-2: INDICATIONS FOR INFANT VENTILATION
EXHIBIT 2-3: SELECTED SUPPLIERS OF INFANT CPAP DEVICES IN 2008
EXHIBIT 2-4: CONVENTIONAL VENTILATION MODES
EXHIBIT 2-5: SELECTED SUPPLIERS OF CONVENTIONAL INFANT VENTILATORS IN 2008
3. INFANT WARMERS AND INCUBATORS
3.1 Infant Warmers
3.1.1 Products and Suppliers
3.2 Infant Incubators
3.2.1 Products and Suppliers
EXHIBIT 3-1: OVERVIEW OF INFANT WARMERS AND INCUBATORS
EXHIBIT 3-2: SELECTED SUPPLIERS OF INFANT WARMERS IN 2008
EXHIBIT 3-3: SELECTED SUPPLIERS OF INFANT INCUBATORS IN 2008
4. JAUNDICE MANAGEMENT PRODUCTS
4.1 Detection of Infant Jaundice
4.2 Treatment of Infant Jaundice
4.3 Products and Suppliers
EXHIBIT 4-1: METHODS FOR DETECTING AND DIAGNOSING NEONATAL JAUNDICE
EXHIBIT 4-2: TREATMENT METHODS FOR NEONATAL JAUNDICE
EXHIBIT 4-3: SELECTED NONINVASIVE HYPERBILIRUBINEMIA DIAGNOSTIC PRODUCTS
AND SUPPLIERS IN 2008
EXHIBIT 4-4: SELECTED PHOTOTHERAPY PRODUCTS AND SUPPLIERS IN 2008
5. PERINATAL AND NEONATAL MONITORING PRODUCTS
5.1 Fetal Heart Rate Monitors
5.1.1 External Fetal Heart Rate Monitors
5.1.2 Internal Fetal Heart Rate Monitors
5.1.3 Products and Suppliers
5.2 Fetal Pulse Oximeters
5.2.1 Products and Suppliers
5.3 Intrauterine Pressure Catheters
5.3.1 Products and Suppliers
5.4 Neonatal Patient Monitoring
5.4.1 Products and Suppliers
EXHIBIT 5-1: PERINATAL AND NEONATAL MONITORING PRODUCTS
EXHIBIT 5-2: METHODS OF MONITORING FETAL HEART RATE
EXHIBIT 5-3: SELECTED PERINATAL MONITORING PRODUCTS AND SUPPLIERS IN 2008
EXHIBIT 5-4: SELECTED INTRAUTERINE PRESSURE CATHETERS AND SUPPLIERS IN 2008
EXHIBIT 5-5: MAJOR MONITORING PARAMETERS INCLUDED IN NEONATAL MONITORS
EXHIBIT 5-6: SELECTED NEONATAL MULTIPARAMETER PATIENT MONITORS AND
SUPPLIERS IN 2008
EXHIBIT 7-1: SELECTED SUPPLIERS OF NEONATAL AND PERINATAL MONITORING &
TREATMENT TECHNOLOGIES IN 2008
GLOBAL MARKETS FOR NEONATAL/PERINATAL MONITORING AND TREATMENT PRODUCTS: U.S., Europe, Rest of World published by Life Science Intelligence, Inc. in October 22, 2008. This report consists of 150 Pages / 65 Exhibits and the price starts from US $ 5995.
Press Release
GLOBAL NEONATAL AND PERINATAL PRODUCT MARKETS SET TO GROW TO OVER $1.5 BILLION BY 2013
November 5th, 2008
According to a new Life Science Intelligence (LSI) report, 2008 Global Markets for Neonatal/Perinatal Monitoring and Treatment Products: U.S., Europe, Rest of World, developing markets for neonatal and perinatal products outside of the U.S. and Europe will experience substantial growth, from $313 million in 2008 to $451 million in 2013. In addition, the report concludes that significant worldwide growth will occur in several product areas, particularly in the infant ventilation and warming segments.
Growth in Asia-Pacific and other international markets will be driven by expanding populations and increasing birth rates, greater demand for these products, and the growing availability of low-cost or locally manufactured technologies. Developing countries account for the vast majority of annual births and preterm infants, which are at risk for developing conditions requiring ventilation, warming therapy, jaundice management, and neonatal monitoring. Driven by a growing middle class, demand is increasing for these products, which are well-established in the developed markets of the U.S., Western Europe, and Japan. The growing availability of low-cost and locally manufactured products will continue to drive sales of new units in these countries.
While the larger U.S. and European markets will not grow at the same pace as Asia-Pacific and Rest of World (ROW) markets through 2013, the substantial revenues that these regions represent will be driven by replacement technologies and accessories. Furthermore, hospitals will continue to prefer devices that offer multiple functions. In infant ventilation, sales will increasingly shift towards comprehensive units capable of treating a full range of patients, including neonatal, pediatric, and adult patients. Hybrid warming devices that can be configured as either open warmers or closed incubators will also be preferred. Specialty products, such as high-frequency ventilators, will also see strong sales growth through 2013. Homecare will represent a growing source for sales of monitoring and jaundice management products.
2008 Global Markets for Neonatal/Perinatal Monitoring and Treatment Products: U.S., Europe, Rest of World covers infant ventilation, warming, jaundice management, and monitoring products in U.S., Europe, Asia-Pacific, and ROW markets. Featured companies include Atom Medical, Draeger Medical (DRW3.F), Fisher & Paykel Healthcare (FPH.NZ), GE Healthcare (GE), Maquet/Getinge (GTN.F), Respironics/Philips Healthcare (PHG), Spacelabs Healthcare/OSI Systems (OSIS), and Viasys/Cardinal Health (CAH).
